Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SpO2 Validation Study - All.Health Algo Oximeter Software

NCT: NCT07527000 · COMPLETED

NCT IDNCT07527000
StatusCOMPLETED
Start Date2026-04-27
Completion2026-05-07

Brief Summary

The clinical use of pulse oximeters has reduced the frequency and necessity of invasive arterial blood sampling and has helped to improve patient safety by providing continuous information to clinicians about patients' oxygenation status. all.health is dedicated to developing and applying innovative electronic medical solutions that improve patient care with the Algo Oximeter Software, to be used in applications for monitoring oxygen saturation.

Frequently Asked Questions

What is SpO2 Validation Study - All.Health Algo Oximeter Software?

SpO2 Validation Study - All.Health Algo Oximeter Software is a clinical trial registered under NCT07527000. Current status: COMPLETED.

What is the status of NCT07527000?

The current status of NCT07527000 (SpO2 Validation Study - All.Health Algo Oximeter Software) is: COMPLETED.

When did SpO2 Validation Study - All.Health Algo Oximeter Software start?

SpO2 Validation Study - All.Health Algo Oximeter Software started on 2026-04-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.